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ORIGINAL RESEARCH
HIV Infection and the Risk of World Health 
Organization– Defined Sudden Cardiac 
Death
Matthew S. Freiberg , MD, MSc; Meredith S. Duncan , PhD; Charles Alcorn, BS; Chung- Chou H. Chang, PhD; 
Suman Kundu , DSc, MSc; Asri Mumpuni, MPH; Emily K. Smith , MPH; Sarah Loch , MPH;  
Annie Bedigian, BS; Eric Vittinghoff , PhD; Kaku So- Armah, PhD; Priscilla Y. Hsue , MD;  
Amy C. Justice, MD, PhD; Zian H. Tseng, MD, MAS
BACKGROUND: People living with HIV have higher sudden cardiac death (SCD) rates compared with the general population. 
Whether HIV infection is an independent SCD risk factor is unclear.
METHODS AND RESULTS: This study evaluated participants from the Veterans Aging Cohort Study, an observational, longitudinal 
cohort of veterans with and without HIV infection matched 1:2 on age, sex, race/ethnicity, and clinical site. Baseline for this 
study was a participant’s first clinical visit on or after April 1, 2003. Participants were followed through December 31, 2014. 
Using Cox proportional hazards regression, we assessed whether HIV infection, CD4 cell counts, and/or HIV viral load were 
associated with World Health Organization (WHO)– defined SCD risk. Among 144 336 participants (30% people living with 
HIV), the mean (SD) baseline age was 50.0 years (10.6 years), 97% were men, and 47% were of Black race. During follow- up 
(median, 9.0 years), 3035 SCDs occurred. HIV infection was associated with increased SCD risk (hazard ratio [HR], 1.14; 95% 
CI, 1.04– 1.25), adjusting for possible confounders. In analyses with time- varying CD4 and HIV viral load, people living with HIV 
with CD4 counts <200 cells/mm3 (HR, 1.57; 95% CI, 1.28– 1.92) or viral load >500 copies/mL (HR, 1.70; 95% CI, 1.46– 1.98) had 
increased SCD risk versus veterans without HIV. In contrast, people living with HIV who had CD4 cell counts >500 cells/mm3 
(HR, 1.03; 95% CI, 0.90– 1.18) or HIV viral load <500 copies/mL (HR, 0.97; 95% CI, 0.87– 1.09) were not at increased SCD risk.
CONCLUSIONS: HIV infection is associated with increased risk of WHO- defined SCD among those with elevated HIV viral load 
or low CD4 cell counts.
Key Words: CD4 cell count ■ HIV infection ■ HIV viral load ■ sudden cardiac death
People living with HIV (PLWH) have an increased risk of acute myocardial infarction,1 ischemic stroke,2 heart failure,3 pulmonary hypertension,4 
and peripheral artery disease5 compared with people 
without HIV. The mechanisms driving this excess risk 
of cardiovascular disease likely involve HIV- specific 
factors including chronic immune activation and in-
flammation,6 antiretroviral therapy– related dyslipid-
emia,7 and behaviors such as smoking and alcohol 
consumption.8 These mechanisms and cardiovascular 
disease are also likely risk factors for sudden cardiac 
death (SCD).9,10 Whether HIV infection is an indepen-
dent risk factor for SCD, however, is unclear because 
data are sparse.9,11,12 The largest study conducted to 
date was our single- site study involving 2860 patients 
at an HIV clinic in San Francisco.9 We reported a rate 
of SCD among PLWH that was 4.5- fold higher than ex-
pected compared with the general population, but our 
study did not account for differences in prevalence of 
cardiovascular risk factors between groups. Whether 
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HIV infection confers an excess risk of SCD compared 
with a population without HIV that is demographically 
and behaviorally similar is unknown.
The objective of this study was to examine the as-
sociation between HIV and SCD in a large national 
cohort of veterans with HIV and demographically and 
behaviorally similar veterans without HIV.
METHODS
Because of the sensitive nature of the data collected 
for this study, requests to access the data set from 
qualified researchers trained in human participant con-
fidentiality protocols may be sent to the VACS (Veterans 
Aging Cohort Study) at matthew.s.freiberg@vumc.org. 
VACS has been described in detail elsewhere13; it is 
a prospective, observational, longitudinal study of vet-
erans with HIV matched 1:2 to veterans without HIV 
on age, sex, race/ethnicity, clinical site, and year of 
enrollment. Study participants were enrolled using a 
previously validated algorithm that leverages the US 
Department of Veteran Affairs (VA) national electronic 
medical record system. All study data were extracted 
from the VA Corporate Data Warehouse or from 
Medicare, Medicaid, or VA fee- for- service administra-
tive files. We performed a retrospective analysis of this 
prospectively gathered data. Vanderbilt University and 
the West Haven VA Medical Center institutional review 
boards approved this study. VACS has a waiver of 
consent as data are partially deidentified. Specifically, 
dates (eg, of hospital encounters and procedures or 
death) are available but other identifiers are lacking and 
investigators have no way of contacting participants. 
Drs Freiberg and Duncan had full access to all of the 
data in this study and are responsible for its integrity 
and the data analysis.
Study Population
For this analysis, we included all VACS participants 
who were alive and enrolled in VACS on or after April 
1, 2003. The baseline date for this study was a VACS 
participant’s first clinical encounter on or after April 1, 
2003. All participants were followed until the first of an 
SCD event, other death event, or December 31, 2014. 
Consistent with prior work examining SCD, we limited 
the participants to those between the ages of 18 to 
90 years.10
Independent Variable
HIV infection was determined using a previously 
validated algorithm consisting of the presence of at 
least one inpatient or two outpatient International 
Classification of Diseases, Ninth Revision (ICD- 9) 
codes for AIDS (042), asymptomatic HIV (V08), and/
or related Diagnostic- Related Group codes (488– 490) 
and inclusion in the VA immunology case registry.13
Dependent Variable
SCD was defined using an algorithm that was based 
on our prior work,9 and combines criteria from the 
World Health Organization (WHO) with a comprehen-
sive chart review.14 The WHO criteria for SCD is the fol-
lowing: (1) sudden unexpected death within 1 hour of 
symptom onset if witnessed or within 24 hours of being 
observed alive and symptom free (unwitnessed).14 For 
our protocol, we employed a 4- step process that in-
cluded: (1) review of each participant’s death cer-
tificate, (2) review of administrative data from the VA 
and Centers for Medicare and Medicaid Services, (3) 
manual review of clinical notes and data closest to the 
CLINICAL PERSPECTIVE
What Is New?
• In this national study, people living with HIV in-
fection have an increased risk of sudden car-
diac death compared with people living without 
HIV infection.
• People living with HIV infection who have un-
suppressed viral load or lower CD4 cell counts 
are at increased risk of sudden death compared 
with people without HIV infection.
What Are the Clinical Implications?
• This study reinforces the need for viral suppres-
sion and heart disease risk factor modification 
among people living with HIV infection.
• For those who have sustained viremia or low 
CD4 cell counts, providers should be aware of 
an excess risk of sudden death; compliance 
with antiretroviral therapy as well as providing 
guideline- based care for cardiovascular risk 
factors is critically important among people liv-
ing with HIV infection.
• Understanding the mechanism underlying this 
excess risk among people living with HIV will be 
important for the prevention of sudden cardiac 
death in this population.
Nonstandard Abbreviations and Acronyms
PLWH people living with HIV
SCD sudden cardiac death
VA Veterans Affairs
VACS Veterans Aging Cohort Study
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date of death that extended up to 1  year before the 
date of death within the VA electronic medical record, 
and (4) a review of non- VA administrative data assess-
ing whether participants were hospitalized outside the 
VA within 1 month of death. The specific algorithm is 
presented in Figure 1 and includes both inclusion and 
exclusion criteria to identify SCD events. Specific steps 
undertaken in the adjudication process are detailed in 
Data S1.
Covariates
All covariates were selected a priori based on clini-
cal judgement and were assessed at baseline by se-
lecting the closest value to the baseline date unless 
otherwise noted. Age, sex, and race/ethnicity were 
determined using administrative data. As previously 
described,1,3,5 clinical outpatient and laboratory data 
were used to assess hypertension, diabetes melli-
tus, hypercholesterolemia, renal disease, body mass 
index, and anemia. Smoking was measured from 
health factors data15 that were collected in a semi-
standardized form within the VA electronic medical 
record. Hepatitis C infection was defined using a pre-
viously validated algorithm including positive hepatitis 
C antibody test results or administrative ICD- 9 codes 
for this diagnosis.16 As we have previously done, prev-
alent alcohol use disorder, cocaine abuse or depend-
ence, cardiovascular disease, and chronic obstructive 
pulmonary disease were assessed using ICD- 9 code 
data.4 Cardiovascular disease was considered preva-
lent (ie, present at or before baseline) if a participant 
had at least 1 inpatient or 2 outpatient ICD- 9 codes 
for prior acute myocardial infarction, coronary ar-
tery revascularization, ischemic stroke, or heart fail-
ure.1,3,5,17 Ever use of QT prolongation medication was 
defined as the use of medications associated with QT 
prolongation (Table S1) at any point before baseline 
through 180 days after baseline. Baseline HIV- specific 
variables including CD4 cell counts, HIV viral load 
data, and antiretroviral therapy were collected within 
180 days on either side of the participant’s baseline 
date. For time- updated analyses, we also collected all 
measures of CD4 cell count and HIV viral load from 
the participant’s baseline date through December 
31, 2014. Antiretroviral therapy was categorized as 
receipt of any therapy that was available on the VA 
formulary (eg, nucleoside reverse transcriptase inhibi-
tor, non- nucleoside reverse transcriptase inhibitor, or 
protease inhibitor). We also assessed receipt of any 
antiretroviral therapy (same definition as baseline plus 
newer medications such as integrase inhibitors) within 
180 days of the date of SCD, non- SCD death, or date 
of last follow- up. VACS investigators have previously 
reported that 96% of veterans with HIV obtain their 
antiretroviral therapies from the VA.13
Missing Data
For this investigation, we used multivariate imputation 
by chained equation techniques that generated 5 com-
plete data sets to handle missing covariate data while 
maintaining the correlation structure. For continuous 
variables, regression- based predictive mean matching 
was utilized to produce biologically plausible imputed 
values while the discriminant function with a nonin-
formative Jeffreys prior was used to impute categorical 
variables.18,19 Results across imputed data sets were 
combined according to Rubin rules.20
Statistical Analysis
Descriptive statistics for all variables by HIV status 
were compared using χ2 test or Fisher exact test for 
categorical variables and Wilcoxon rank sum test for 
continuous variables. We calculated SCD incidence 
rates per 100 000 person- years stratified first by HIV 
status, next by baseline HIV viral load and CD4 cell 
count, and then decade age group. We additionally 
plotted cumulative SCD incidence by HIV status. We 
constructed 3 sets of Cox proportional hazard regres-
sion models to assess SCD risk and estimate hazard 
ratios (HRs) and corresponding 95% CIs for the fol-
lowing groups compared with those without HIV: (1) 
PLWH as a whole; (2) PLWH with CD4 ≥500, PLWH 
with 200≤CD4<500, and PLWH with CD4 <200; and 
(3) PLWH with a viral load <500 and PLWH with a viral 
load ≥500. In each set of models we performed a mini-
mally adjusted regression that included age, sex, race/
ethnicity, and prevalent CVD as covariates, as well 
as multivariable- adjusted models that additionally in-
cluded hypertension, diabetes mellitus, low- and high- 
density lipoprotein cholesterol, triglycerides, hepatitis 
C infection, smoking status, renal disease, body mass 
index, anemia, cocaine dependence or abuse, alcohol 
dependence or abuse, chronic obstructive pulmonary 
disease, and use of QT prolongation medications as 
covariates. For these multivariable- adjusted primary 
models, we repeated the analysis using HIV viral load 
and/or CD4 cell count data as time- varying covariates 
such that each participant contributed person- time to 
the CD4 cell count or HIV viral load category reflecting 
their status at each biomarker assessment For exam-
ple, if a PLWH had 3 years of follow- up with a CD4 cell 
count of 250 cells/mm3 at baseline, 300 cells/mm3 at 
6 months, and 550 cells/mm3 at 1.5 years, they would 
contribute 0 to 1.5 years of their follow- up time to the 
200≤CD4<500 cells/mm3 group, and 1.5 to 3 years to 
the CD4 ≥500  cells/mm3 group. For individuals who 
experienced SCD, the death contributed to the group 
in which the participant held membership on the date 
of death. From the multivariable- adjusted models with 
HIV status (yes/no) as the primary exposure of inter-
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Figure 1. Sudden cardiac death (SCD) adjudication and sample derivation.
CMS indicates Centers for Medicare and Medicaid Services; DNI, do not intubate; DNR, do not resuscitate; 
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incidence by HIV status. Because the prevalence of 
cigarette smoking was higher in our sample than in the 
general population, we performed a sensitivity analysis 
in which we limited the sample to never- smokers and 
reassessed the association between HIV status and 
SCD.
Cox proportional hazards regression models were 
then stratified by HIV status to assess SCD risk factors; 
CD4 cell count and HIV viral load were time- varying in 
models restricted to PLWH. We then assessed SCD 
risk stratified by HIV status across a set of SCD risk 
factors identified from the previous models (prevalent 
CVD, hypertension, current smoking, hepatitis C infec-
tion, anemia, alcohol use disorder, chronic obstructive 
pulmonary disease) by calculating the incidence rate 
per 100  000 person- years and HRs compared with 
those with 0 risk factors. Incidence rates and HRs were 
adjusted for age, sex, race/ethnicity, CD4 cell count 
(PLWH only), and HIV viral load (PLWH only). Incidence 
rates were estimated using Poisson regression assum-
ing the number of SCD risk factors was a categorical 
variable, while in Cox proportional hazards regression 
models the number of SCD risk factors was modeled 
using restricted cubic splines with 3 knots. The spline 
was tested for departure from linearity via a likelihood 
ratio test. The proportional hazards assumption was 
not violated for the main predictor (HIV infection status) 
using the log- log survival plot. Although the full VACS 
cohort is matched, matching was not preserved fol-
lowing exclusions, thus analyses did not account for 
matching. A 2- sided P value of <0.05 was used to de-
termine statistical significance, and all analyses were 
performed using SAS version 9.4 (SAS Institute Inc).
RESULTS
Participant Characteristics
This analysis included 144  336 participants (43  407 
[30%] were veterans with HIV) at baseline. The me-
dian age of participants at baseline was 50 years and 
the majority were men and either Black or White par-
ticipants (Table 1). Veterans without HIV had a higher 
prevalence of hypertension, diabetes mellitus, elevated 
low- density lipoprotein cholesterol, obesity, alcohol 
use disorders, chronic obstructive pulmonary disease, 
and cardiovascular diseases than veterans with HIV 
but lower prevalence of low high- density lipoprotein 
cholesterol, elevated triglycerides, current smoking, 
hepatitis C infection, and history of cocaine abuse and 
dependence (Table  1). At baseline, among veterans 
with HIV, the median CD4 cell count was 385  cells/
mm3 and median HIV type 1 RNA was 999  copies/
mL; 39.5% were taking antiretroviral therapy. Within 
180 days of the date of last follow- up, 72.6% of veter-
ans with HIV were taking antiretroviral therapy.
Unadjusted SCD Incidence Rates
During a median follow- up of 9.0 years, 3035 SCDs 
occurred, with 777 (26%) in veterans with HIV. 
Unadjusted SCD rates per 100  000 person- years 
for veterans with HIV and veterans without HIV were 
232 (95% CI, 215– 249) and 234 (95% CI, 224– 246), 
respectively (Table  2). SCD rates increased with in-
creasing decade of age for both veterans with HIV 
and those without HIV but there was no difference by 
HIV status within age groups (Table 3). For veterans 
with HIV, SCD rates also increased with decreasing 
baseline CD4 cell counts and increasing HIV viral load 
(Table 2).
Adjusted SCD Risk by HIV Status and 
Measures of HIV Control
Compared with veterans without HIV, veterans with 
HIV had a 14% increase in SCD risk after adjusting 
for confounders (Table 2 and Figure 2). This risk was 
29% higher among veterans with HIV who had base-
line CD4 cell counts <200 cells/mm3, and 17% higher 
among veterans with HIV with a baseline HIV viral load 
≥500 copies/mL, both compared with veterans with-
out HIV (Table 2).
In analyses with time- varying viral load and CD4 cell 
counts (the median number of counts for both tests 
during follow- up were 12 per participant), CD4 cell 
counts <200 cells/mm3 in veterans with HIV was as-
sociated with a 57% (HR, 1.57; 95% CI, 1.28– 1.92) in-
creased risk of SCD compared with veterans without 
HIV (Table 2). Similarly, HIV viral loads >500 copies/
mL among veterans with HIV was associated with a 
70% (HR, 1.70; 95% CI, 1.46– 1.98) increased risk of 
SCD compared with veterans without HIV (Table 2). 
In contrast, time- varying CD4 cell counts >500 cells/
mm3 and HIV viral loads <500  copies/mL in veter-
ans with HIV were not associated with an increased 
risk of SCD as compared with veterans without HIV 
(Table 2).
In our sensitivity analysis limited to never- smokers, 
we observed that HIV infection was associated with 
a 41% increased risk of SCD (HR, 1.41; 95% CI, 1.13– 
1.76) after multivariable adjustment.
SCD Risk Factors by HIV Status
Among veterans with HIV, age, male sex, cardiovas-
cular disease, hypertension, current smoking, hepatitis 
C infection, increasing body mass index, anemia, al-
cohol use disorder and chronic obstructive pulmonary 
disease were all associated with higher risk of SCD 
(P<0.05 for all, Table 4). These risk factors, plus ele-
vated low- density lipoprotein cholesterol and diabetes 
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In both veterans with and without HIV, the rates 
and risk of SCD increased with increasing number 
of SCD risk factors (Figure 3). For those with no risk 
factors, SCD rates were low (Figure  3). The asso-
ciation between log- hazards of SCD and number 
of SCD risk factors did not significantly differ from 
linearity among veterans with HIV, but was nonlin-
ear among veterans without HIV (test for departure 
from linearity: P valueveterans without HIV infection=0.003; P 
valueveterans with HIV=0.26). When assuming a log- linear 
Table 1. Baseline Characteristics of VACS Participants 









Mean (SD) 49.2 (10.7) 50.1 (10.6)
Median 49.0 50.0






History of CVD, % 13.7 17.7





Diabetes mellitus 11.4 19.1
Lipids, mg/dL†
LDL- C <100 47.9 36.1
LDL- C 100– 129 29.4 32.5
LDL- C 130– 159 15.5 20.6
LDL- C ≥160 7.2 10.8
HDL- C ≥60 11.6 14.0
HDL- C 40– 59 38.0 46.9
HDL- C <40 50.4 39.1





Other risk factors, %
Hepatitis C infection, %
Negative 65.0 63.1
Positive 29.0 13.6
Never tested 6.0 23.4
Renal disease, mL/min per 1.73 m2†
eGFR ≥60 91.6 92.8
eGFR <60 8.4 7.2
BMI, kg/m2†
Mean (SD) 25.8 (4.9) 29.5 (6.1)
Median 25.2 28.8
Anemia, g/dL†
Hemoglobin ≥14 54.1 70.4
Hemoglobin 12– 13.9 32.4 24.8
Hemoglobin 10– 11.9 10.5 4.0









History of alcohol abuse, % 25.7 26.4
History of cocaine abuse, % 18.9 14.5
Chronic obstructive pulmonary 
disease, %
11.2 12.2
QT prolongation medication, % 57.0 45.0
HIV- specific variables‡
CD4 cell count, cells/mm3†
Mean (SD) 428.1 (296.7) …
Median 385.0 …
HIV type 1 RNA, copies/mL†





Nucleoside reverse transcriptase 
inhibitor+protease inhibitor
17.1 …




Other combinations 9.4 …
No antiretroviral therapy 60.5 …
SI conversion factors: to convert high- density lipoprotein cholesterol 
(HDL- C) and low- density lipoprotein cholesterol (LDL- C) to millimoles per 
liter, multiply by 0.0259; hemoglobin to grams per liter, multiply by 10; 
and triglycerides to millimoles per liter, multiply by 0.0113. CVD indicates 
cardiovascular disease; and VACS, Veterans Aging Cohort Study.
*All characteristics were statistically different among veterans with and 
without HIV (P<0.05) using χ2 test or Wilcoxon rank sum test except sex 
(P=0.51).
†All variables had complete data except the following: hypertension 
data were available on 42 741 (people living with HIV [PLWH]) and 96 489 
(uninfected); LDL- C data were available on 34  991 (PLWH) and 80  304 
(uninfected); HDL- C data were available on 35  469 (PLWH) and 81  108 
(uninfected); triglyceride data were available for 36 012 (PLWH) and 81 022 
(uninfected); smoking data were available on 30  304 (PLWH) and 72  244 
(uninfected); hepatitis C infection data were available on 43  249 (PLWH) 
and 100  593 (uninfected); estimated glomerular filtration rate (eGFR) data 
were available on 40 857 (PLWH) and 90 488 (uninfected); body mass index 
(BMI) data were available on 41 716 (PLWH) and 94 141 (uninfected); anemia 
data were available on 41  173 (PLWH) and 89  540 (uninfected); CD4 cell 
count data were available on 35 219 (PLWH); and HIV type 1 RNA data were 
available on 35 177 (PLWH).
‡Because veterans without HIV do not have HIV- specific biomarkers or 
antiretroviral therapy regimens, these cells contain only dashes.
§Other includes American Indian/Alaska Native, Asian, Native Hawaiian/
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association between number of risk factors and risk 
of SCD we observed that among veterans with HIV, 
SCD risk increased by 1.49- fold (95% CI, 1.40– 1.58) 
for each additional SCD risk factor. As there was a 
significantly nonlinear association between number 
of risk factors and risk of SCD in veterans without 
HIV infection, there is not a single summary mea-
sure to report that describes the increase in SCD 
risk per additional SCD risk factor; the association is 
depicted in panel B of Figure 3.
DISCUSSION
In VACS, veterans with HIV had an increased risk of 
WHO- defined SCD compared with veterans with-
out HIV when the virus was not suppressed or when 











Adjusted SCD risk 
with time- varying HIV 
biomarkers (95% CI)§
Stratified by HIV status
HIV− 43 407 2258 234 (224– 246) 1.00 1.00 …
HIV+ 100 929 777 232 (215– 249) 1.00 (0.92– 1.08) 1.14 (1.04– 1.25) …
Stratified by HIV status and CD4 cell count
HIV− 100 929 2258 235 (224– 246) 1.00 1.00 1.00
HIV+, CD4 ≥500 12 308 214 222 (194– 254) 0.96 (0.83– 1.11) 1.09 (0.95– 1.26) 1.03 (0.90– 1.18)
HIV+, 200 ≤CD4<500 14 592 256 219 (194– 248) 0.96 (0.85– 1.09) 1.13 (0.99– 1.28) 1.11 (0.96– 1.28)
HIV+, CD4 <200 8319 144 259 (220– 305) 1.13 (0.95– 1.34) 1.29 (1.07– 1.56) 1.57 (1.28– 1.92)
HIV+, missing CD4‖ 8188 163 245 [210– 287] … … …
Stratified by HIV status and viral load
HIV− 100 929 2258 235 [224, 246] 1.00 1.00 1.00
HIV+, VL <500 16 147 303 220 [196, 246] 0.97 [0.87, 1.08] 1.12 [1.00, 1.26] 0.97 [0.87, 1.09]
HIV+, VL ≥500 19 031 312 238 [213, 266] 1.03 [0.92, 1.15] 1.17 [1.04, 1.31] 1.70 [1.46, 1.98]
HIV+, missing VL‖ 8230 162 243 [208, 284] … … …
PY indicates person- years; and SCD, sudden cardiac death.
*Values correspond to the analysis using baseline values of CD4 and HIV viral load, not the time- updated analysis.
†Adjusted for age, sex, race/ethnicity, and prevalent cardiovascular disease (CVD).
‡Adjusted for age, sex, race/ethnicity, hypertension, diabetes mellitus, low- and high- density lipoprotein cholesterol, triglycerides, hepatitis C infection, 
smoking status, renal disease, body mass index, anemia, cocaine dependence or abuse, alcohol dependence or abuse, chronic obstructive pulmonary 
disease, use of QT prolongation medications, and prevalent CVD.
§Adjusted for all factors in (‡) but CD4 and viral load are time updated.
‖Missing category used only for calculation of incidence rates. For models, missing CD4 cell counts were imputed.
Table 3. Rates of SCD Per 100 000 Person- Years by Decade of Age and HIV Status
Statistic
Age group, y
<30 30– 39 40– 49 50– 59 60– 69 70– 79 80– 89
Uninfected
Participants, n 3766 10 986 32 921 36 635 12 614 3439 568
SCDs, n 5 53 629 1086 336 130 19
SCD rates per 
100 000 PY (95% CI)
25 (10– 59) 58 (44– 75) 215 (199– 233) 366 (344– 388) 410 (369– 456) 577 (486– 685) 671 (428– 1052)
HIV infected
Participants, n 1886 5433 14 622 14 933 5048 1295 190
SCDs, n 2 25 248 340 121 37 4
SCD rates per 
100 000 PY (95% CI)
19 (5– 77) 57 (39– 85) 212 (187– 240) 326 (293– 363) 428 (358– 511) 525 (380– 724) 519 (195– 1382)
Incidence rate ratio 
(95% CI)
0.78 (0.15– 4.02) 0.99 (0.62– 1.60) 0.98 (0.85– 1.14) 0.89 (0.79– 1.01) 1.04 (0.85– 1.28) 0.91 (0.63– 1.31) 0.77 (0.26– 2.27)
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CD4 cell counts were low. Traditional cardiovascular 
disease risk factors, hepatitis C infection, alcohol use 
disorder, anemia, and chronic obstructive pulmonary 
disease were also associated with an increased risk 
of SCD regardless of HIV status. Among veterans with 
HIV, the risk of SCD increased by 49% with each ad-
ditional SCD risk factor.
To our knowledge, this is the largest study to date 
reporting that PLWH have an excess risk of SCD and 
the only national study to compare PLWH with a de-
mographically and behaviorally (eg, substance use and 
abuse) similar uninfected reference population that in-
cluded adjudicated SCDs. These findings are consis-
tent with earlier reports by our group and others of an 
excess risk of SCD among PLWH9,11,12 and extend prior 
work by including participants without existing heart 
failure and assessing the impact of time- updated viral 
load status and immune function over a median fol-
low- up period of 9  years. Notably, the magnitude of 
increased SCD risk in HIV- infected versus uninfected 
veterans in the current study is substantially lower than 
our 2012 study, which compared SCD rates in our 
specialty HIV clinic over 10  years with the expected 
SCD rate in the uninfected county- wide population.9 
As such, the groups in our first study were not de-
mographically and behaviorally similar, and variables 
known to increase risk of SCD such as coronary ar-
tery disease, smoking, and heart failure were higher in 
PLWH. Indeed, a major strength of the current study 
is that we accounted for major differences in risk fac-
tor prevalence between comparator groups, allowing 
us to more accurately estimate the excess risk of SCD 
associated with HIV infection. In VACS, this excess risk 
of SCD was not initially present in unadjusted analyses 
because the uninfected veterans had a higher burden 
of SCD risk factors including prevalent cardiovascular 
disease.
While the exact mechanism underlying this excess 
SCD risk remains unknown, it is likely multifactorial and 
linked to both HIV infection and the burden of SCD risk 
factors. Prior studies link HIV infection to cardiovascu-
lar disease,21 inflammation,6 atrial fibrillation,22 auto-
nomic dysfunction,23 QT prolongation,24 heart failure,3 
low ejection fraction,25 and cardiac fibrosis,26 each of 
which may play a role in SCD. The latter is present even 
among PLWH without ischemic cardiomyopathy26 and 
Figure 2. Multivariable- adjusted cumulative sudden cardiac death (SCD) incidence by HIV status.
Adjusted incidence output from a Cox proportional hazards regression model adjusted for age, sex, race/
ethnicity, hypertension, diabetes mellitus, low- and high- density lipoprotein cholesterol, triglycerides, 
hepatitis C infection, smoking status, renal disease, body mass index, anemia, cocaine dependence or 
abuse, alcohol dependence or abuse, chronic obstructive pulmonary disease, use of QT prolongation 
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is associated with low CD4 cell counts and biomarkers 
of inflammation in humans27 and depletion of T regu-
latory cells in murine models.28 The increased risk of 
SCD among those with sustained elevation in viremia 
and low CD4 cell counts is also consistent with ear-
lier reports examining HIV infection and other cardio-
vascular diseases.1,3,5,17 Prior studies show that high 
viral loads and immunodeficiency increase the levels 
of inflammation,29 monocyte activation,30,31 and al-
tered coagulation,6 which, in turn, are associated with 
an increased risk of incident cardiovascular disease, 
and is itself a major risk factor for SCD in the general 
population.10
Our findings have important implications for PLWH 
and people without HIV and their providers. First, for 
PLWH, viral load suppression may reduce risk of sud-
den death. We did not observe an excess risk of WHO- 
defined SCD among veterans with HIV when CD4 
counts were >500  cells/mm3 or viral load remained 
<500 copies/mL in time- updated analyses. By the end 
of this study, nearly 3 of 4 veterans with HIV were tak-
ing antiretroviral therapy within 6 months of their date 
of death or last follow- up. Our findings are consistent 
with trials reporting that viral suppression lowers the 
risk of future non- AIDS outcomes, including cardiovas-
cular disease.32,33 Second, for both PLWH and peo-
ple without HIV infection, preventing or appropriately 
managing SCD risk factors could have a profound im-
pact on SCD risk. This is consistent with earlier work 
by Althoff et al,34 who reported that a substantial por-
tion of non- AIDS diseases (eg, cancer, renal disease, 
and myocardial infarctions) could be prevented with 
interventions on traditional risk factors. Additionally, 
if confirmed in other studies, targeting hepatitis C in-
fection and hazardous alcohol consumption may also 
reduce the risk of sudden death among PLWH. The 
significance of anemia and the risk of SCD in this study 
Table 4. Associations Between Clinical Characteristics 







Age, 10 y 1.53 (1.39– 1.69) 1.31 (1.25– 1.38)
Male sex 2.32 (1.03– 5.23) 2.86 (1.74– 4.70)
Race/ethnicity
Black vs White 0.75 (0.62– 0.90) 0.98 (0.90– 1.08)
Hispanic vs White 0.52 (0.35– 0.77) 0.62 (0.51– 0.76)
Other ‡vs White 1.73 (1.16– 2.59) 1.22 (0.97– 1.52)
Prevalent CVD 1.77 (1.44– 2.17) 2.12 (1.93– 2.33)
Hypertension
Controlled vs none 1.66 (1.33– 2.07) 1.65 (1.43– 1.89)
Uncontrolled vs none 1.65 (1.31– 2.07) 2.02 (1.76– 2.32)
Diabetes mellitus 1.23 (0.97– 1.55) 1.44 (1.30– 1.59)
Lipids, mg/dL
LDL- C 100– 129 vs <100 1.07 (0.86– 1.33) 1.03 (0.91– 1.16)
LDL- C 130– 159 vs <100 1.00 (0.77– 1.29) 1.14 (0.99– 1.30)
LDL- C ≥160 vs <100 1.38 (1.00– 1.92)† 1.32 (1.14– 1.53)
HDL- C 40– 59 vs ≥60 0.66 (0.50– 0.86) 0.81 (0.70– 0.93)
HDL- C <40 vs ≥60 0.73 (0.55– 0.96) 0.85 (0.73– 0.99)
Triglycerides ≥150 vs <150 1.00 (0.82– 1.22) 0.99 (0.89– 1.09)
Smoking
Current vs never 1.57 (1.18– 2.08) 1.92 (1.67– 2.22)
Former vs never 0.85 (0.57– 1.25) 1.14 (0.97– 1.35)
Hepatitis C virus infection
Positive vs negative 1.40 (1.16– 1.70) 1.26 (1.12– 1.42)
Never tested vs negative 2.80 (1.99– 3.94) 1.85 (1.68– 2.05)
Renal disease, mL/min per 1.73 m2
eGFR <60 vs ≥60 0.81 (0.59– 1.10) 1.00 (0.86– 1.17)
BMI, 5 kg/m2 1.12 (1.02– 1.23) 1.06 (1.02– 1.10)
Anemia, g/dL
Hemoglobin 12– 13.9 vs ≥14 1.46 (1.22– 1.76) 1.13 (1.02– 1.26)
Hemoglobin 10– 11.9 vs ≥14 1.60 (1.20– 2.14) 1.42 (1.16– 1.74)
Hemoglobin <10 vs ≥14 1.83 (1.05– 3.19) 1.73 (1.12– 2.69)
History of alcohol abuse 1.40 (1.12– 1.76) 1.76 (1.58– 1.97)
History of cocaine abuse 0.89 (0.69– 1.15) 0.88 (0.77– 1.01)
Chronic obstructive 
pulmonary disease
1.35 (1.07– 1.69) 1.32 (1.19– 1.47)
QT prolongation medication 0.88 (0.73– 1.05) 1.04 (0.95– 1.13)
CD4 cell count, mm
200– 499 vs ≥500 1.03 (0.86– 1.24) …
<200 vs ≥500 1.33 (1.04– 1.71) …
HIV viral load, copies/mL


















inhibitor vs no therapy
0.97 (0.77– 1.21) …
Other vs no therapy 0.87 (0.67– 1.13) …
BMI indicates body mass index; CVD, cardiovascular disease; eGFR, 
estimated glomerular filtration rate; HDL- C, high- density lipoprotein 
cholesterol; HR, hazard ratio; LDL- C, low- density lipoprotein cholesterol; and 
SCD, sudden cardiac death.
*Models adjusted for all listed characteristics were run separately for 
veterans with and without HIV infection.
†P- value> 0.05.
‡Other includes American Indian/Alaska Native, Asian, Native Hawaiian/
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remains unclear. However, anemia increases risk for 
myocardial ischemia and our prior work shows that 
anemia in PLWH is significantly associated with bio-
markers of inflammation, monocyte activation, and al-
tered coagulation.35 While there are no risk prediction 
tools for SCD among PLWH, identifying patients with 
a high burden of SCD risk factors (Table 4, Figure 3) 
may help risk stratify patients at risk for SCD. Future 
studies could focus on a risk prediction tool as well as 
the underlying mechanism(s) for this excess SCD risk.
Our investigation also has limitations that warrant 
discussion. First, our study does not have autopsy 
data, which is the gold standard for adjudication of 
conventionally defined SCD. As such we do not know 
the exact cause of death, which is especially import-
ant as nearly half of WHO- defined SCDs may not be 
cardiac.10 Moreover, as compared with the general 
population, HIV- related causes and occult drug over-
dose are more common among PLWH, which could 
result in a differential misclassification of SCD and by 
extension a higher risk of WHO- defined SCD among 
PLWH.36 However, one of the major strengths of our 
approach was the review of participants’ charts for 
any HIV- related diseases (eg, pneumocystis pneumo-
nia) that occurred within 1 year of the date of death, 
and a comparator group without HIV infection that was 
behaviorally similar to our group of veterans with HIV. 
By comparing veterans who had HIV with veterans 
without HIV who have similar rates of smoking, alco-
hol use disorder, cocaine use disorder, and opioid use, 
we reduced the possibility of differential misclassifi-
cation of SCD by HIV status in this study.37 Second, 
we acknowledge that some bias may have occurred 
by evaluating PLWH who had underlying cause of 
death as HIV/AIDS and a CVD cause of death in the 
first position for SCD. However, after consultation with 
HIV disease experts, we concluded that there was a 
larger concern for bias if we excluded these deaths 
without review. More specifically, there was a con-
cern that physicians, particularly in the early 2000s, 
would state an HIV cause of death in the underlying 
position even when that was not the actual cause of 
death. Third, we were not able to contact next of kin to 
gain additional information about symptoms or factors 
immediately associated with the time of death; there-
fore, the timeline of suddenness could not be verified. 
Fourth, while we had access to the entire VA electronic 
medical record and non- VA administrative data from 
Medicare, Medicaid, and VA fee- for- service files, we 
were not able to review detailed clinical notes outside 
the VA that were not incorporated into the VA electronic 
medical record. Fifth, these data do not suggest that 
the recommendations for implantable cardioverter- 
defibrillator placement be different for PLWH than in 
the general population. Sixth, the participants of our 
study have a higher prevalence of cigarette smoking 
than the general US population, which may limit the 
generalizability of our results. However, in a sensitivity 
analysis limited to never- smokers, our primary results 
held. Last, as our sample included an overwhelming 
number of men, our findings may not be generalizable 
to women. Additional studies among PLWH including a 
larger proportion of women are needed to further elu-
cidate this association in women.
CONCLUSIONS
HIV infection is associated with an increased risk of 
WHO- defined SCD. This risk was present among 
Figure 3. Sudden cardiac death (SCD) risk among people living with HIV (PLWH) and veterans without HIV by number of 
SCD risk factors.
A, Among PLWH and (B) among those without HIV. SCD risk factors: prevalent cardiovascular disease, hypertension, current smoking, 
hepatitis C infection, anemia, alcohol use disorder, chronic obstructive pulmonary disease. Incidence rates and hazard ratios (HRs) 
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those with poor HIV disease control and/or a high bur-
den of SCD risk factors but not among those with viral 
suppression or high CD4 cell counts. Traditional car-
diovascular disease risk factors, hepatitis C infection, 
anemia, alcohol use disorder, and chronic obstructive 
lung disease were all associated with an increased risk 
of SCD. Our data suggest that treating HIV infection 
and the associated risk factors for SCD could reduce 
SCD risk among PLWH. Future studies should exam-
ine the underlying mechanisms for SCD among PLWH.
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Data S1. Steps to adjudicate SCD in our data. 
 
Step 1: There were 27,087 deaths in the VACS. To be included as a SCD event, all participants 
had to have a cardiovascular disease cause of death in the underlying position on the death 
certificate. The only exception to this rule was for Veterans with HIV who had an HIV/AIDS 
cause of death in the underlying position and a cardiovascular disease cause in the first position 
on the death certificate. We included this latter provision, because we were concerned that 
providers, particularly early on in the highly active antiretroviral therapy era, may have listed an 
HIV/AIDS cause of death as the underlying cause even when a cardiac cause was the actual 
cause of death. 
Once participants were identified with a cardiovascular disease cause of death, then a 
series of exclusion criteria were implemented to ensure that the death was not due to a non-SCD 
cause. For this process, we again reviewed the death certificate and determined a person could 
not have died of SCD if there was any mention of accident, suicide, homicide, or overdose in any 
position on the death certificate. These latter deaths were excluded because they do not meet the 
WHO definition of “unexpected death.”  
Step 2: After reviewing death certificates, we examined administrative data on the remaining 
13,716 death events to ensure that the death occurred outside of the hospital, nursing home, 
hospice, or ED with an order to admit. Lastly, consistent with prior studies, SCD events were 
excluded among those who had end-stage renal disease and were on hemodialysis.(10)  
Step 3: After reviewing the administrative data, we manually reviewed the VA EMR of the 
remaining death events (n=9,696) to identify deaths that may have been attributed to cancer, end-








specific/significant recent onset of complaints within one month prior to death (e.g., died at 
home soon after undergoing coronary artery bypass graft and mitral valve replacement surgery) 
or debilitating new diagnosis within one year of death (e.g., had ischemic stroke followed by two 
months of rehabilitation and then died after being discharged to home). 
Step 4: Among the 3,383 deaths that remained after manual chart review, we further excluded 
any deaths if the participant was hospitalized outside the VA within one month of death based on 
a review of Medicare, Medicaid, and VA fee-for-service administrative data. Among those 
remaining after these exclusion criteria (n=3,100 deaths), we further excluded deaths for those 
participants who had missing follow-up time (48 events), events among those who seroconverted 
during follow-up (2 events), and events among Veterans without HIV with measured CD4 or 
HIV viral load leading to uncertainty regarding HIV status (15 events). After all exclusions, we 
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